These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27002311)

  • 1. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
    Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
    Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human leukocyte antigen immunologic risk stratification methods in lung transplantation.
    Hiho SJ; Levvey BJ; Diviney MB; Snell GI; Sullivan LC; Westall GP
    Am J Transplant; 2024 May; 24(5):827-838. PubMed ID: 37981213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant.
    Walton DC; Cantwell L; Hiho S; Ta J; Wright S; Sullivan LC; Snell GI; Westall GP
    Transpl Immunol; 2018 Dec; 51():73-75. PubMed ID: 30321645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation.
    Kleid L; Walter J; Moehnle P; Wichmann C; Kovács J; Humpe A; Schneider C; Michel S; Kneidinger N; Irlbeck M; Fertmann J; Dick A; Kauke T
    Transpl Int; 2024; 37():13010. PubMed ID: 39381015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases.
    Courtwright AM; Diamond JM; Sandorfi N; Goldberg HJ
    Clin Transplant; 2024 Aug; 38(8):e15426. PubMed ID: 39136242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation.
    Ennis SL; Olsen N; Tong WWY; Goddard L; Watson N; Weston L; Iqbal A; Patel P; Malouf MA; Plit ML; Darley DR
    Am J Transplant; 2023 Jul; 23(7):1009-1021. PubMed ID: 37054889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.
    Calhoun R; SivaSai KS; Sundaresan S; Trulock EP; Lynch JP; Patterson GA; Cooper JD; Mohanakumar T
    Transpl Int; 1999; 12(6):439-46. PubMed ID: 10654356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
    Yanyiam P; Kantachuvesiri S; Thammanichanond D
    Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.
    McCaughan JA; Battle RK; Singh SKS; Tikkanen JM; Moayedi Y; Ross HJ; Singer LG; Keshavjee S; Tinckam KJ
    Am J Transplant; 2018 Dec; 18(12):2924-2933. PubMed ID: 29847022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients.
    Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ
    J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching.
    Kosmoliaptsis V; Mallon DH; Chen Y; Bolton EM; Bradley JA; Taylor CJ
    Am J Transplant; 2016 Jul; 16(7):2139-47. PubMed ID: 26755448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation.
    González-López E; Mora-Cuesta VM; Roa-Bautista A; Comins-Boo A; Renaldo A; Irure-Ventura J; Iturbe-Fernández D; Tello-Mena S; San Segundo D; Cifrián-Martínez J; López-Hoyos M
    Transplant Direct; 2023 Jul; 9(7):e1513. PubMed ID: 37389015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.